Química Farmacéutica
Permanent URI for this collection
Browse
Browsing Química Farmacéutica by Author "Chamorro Rengifo, Andrés Felipe (Director)"
Now showing 1 - 2 of 2
Results Per Page
Sort Options
Item Análisis de cumplimiento y mejoras potenciales en cosméticos con cannabis o sus derivados en establecimientos farmacéuticos de Cali: Un enfoque en la decisión 833 de 2018(Universidad Santiago de Cali, 2024) Gutierrez Corral, Miguel Angel; Amaya Londoño, Nicolas Giuseppe; Chamorro Rengifo, Andrés Felipe (Director)Cannabis, a plant with a history spanning over 4000 years, has played a vital role in various cultures, from ancient China to pre-Columbian civilizations. Initially revered for its medicinal and spiritual properties, cannabis has faced stigmatization in the modern era due to political and social influences. However, in recent decades, it has experienced a resurgence in the pharmaceutical and cosmetic fields, supported by scientific evidence of its efficacy in treating various conditions. Cannabis regulation varies by country, ranging from legalization to prohibition. In the cosmetic realm, it has become a popular ingredient due to its moisturizing and antioxidant properties. However, lack of compliance with regulations can compromise consumer safety. Evaluating compliance of cannabis products at the regulatory level is necessary to protect the population from the use of illegal products that may jeopardize health. According to this study, which focused on evaluating compliance of cosmetic products with cannabis in the city of Cali with Decision 833 of 2018 (Colombian regulation?), surveys and pie charts were used to assess labeling and consumer safety compliance. The results indicate that a important proportion of respondents (35.7%) are unaware of the existence of Decision 833 of 2018, 50% do not verify or review mandatory health notifications, and 80,6% do not review mandatory warnings on labels. This demonstrates a lack of awareness regarding the importance of health registration and mandatory warnings on labels, raising concerns about consumer safety. Increasing transparency, education, and regulation in the industry is recommended to enhance consumer confidence and ensure product safety.Item Estandarización de medicamentos de pediatría en un Hospital Público Nivel 1 de la Ciudad de Cali(Universidad Santiago de Cali, 2023) Hidalgo Giraldo, Laura Marcela; Chamorro Rengifo, Andrés Felipe (Director)This project standardizes the method of preparation, stability time and concentration of the drugs Amikacin 500 mg/2 mL, Betamethasone 4 mg/1 mL, Cephalexin 250 mg/5 mL, Cefradine 1 g, Furosemide 20 mg/2 mL, Penicillin g benzathine 2,400,000 U. I and Penicillin g sodium 5,000,000 U. I in a pediatric service in a public hospital of level one in the city of Cali, Colombia, from the development by non-sequential stages, and a quantitative methodology to collect information with closed questions, and open, with measurable answers to the nursing staff, about general knowledge of the administration of the seven medications. In this, the development of a table of dilution and stabilities of the drugs, and a guide for their safe use is achieved. Finally, it is important to strengthen patient safety, focused on the use of medications, because when considering the physiological conditions of pediatric patients, it is a requirement to have greater caution when administering medications; Likewise, the importance of implementing this type of documents in the institution is determined, in order to mitigate the occurrence of errors and adverse events associated with medications.